Clinical Study

A Prospective Study Evaluating IOP Changes after Switching from a Therapy with Prostaglandin Eye Drops Containing Preservatives to Nonpreserved Tafluprost in Glaucoma Patients

Table 1

Mean daily IOP at baseline and after 3 months of treatment with tafluprost.

Baseline IOP After 3 months of tafluprost Mean IOP change Mean % IOP changeP value

Latanoprost, travoprost, or bimatoprost treatment 1 6 ± 2 . 1  mmHg 1 6 . 6 ± 2 . 0  mmHg+0.6 mmHg+3.75%>0.05